TG Therapeutics | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 3.32B 2.71B 2024-12
Alaunos Therapeutics USD 2.72M 1.05M 2024-09
Amgen USD 5.88B 1.65B 2024-12
Ardelyx USD 173.29M 14.99M 2024-12
Arrowhead Research USD 52.59M 132.85M 2024-12
Bayer EUR 32.04B 1.49B 2024-12
Biogen USD 16.72B 357.1M 2024-12
Corcept Therapeutics USD 679.59M 40.75M 2024-12
Dynavax Technologies USD 596.8M 84.63M 2024-12
Gilead Sciences USD 19.33B 856M 2024-12
J&J USD 71.49B 1.33B 2024-12
Novartis USD 44.05B 605M 2024-12
PTC Therapeutics USD -1098071000 43.72M 2024-12
Regeneron Pharmaceuticals USD 29.35B 27.7M 2024-12
Roche Holding CHF 36.16B 3.28B 2024-12
TG Therapeutics USD 222.36M 30.21M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



TG Therapeutics Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.